Technology

Selecta Biosciences CEO Dr. Werner Cautreels talks about the company's innovative technology and how his entrepreneurial experiences in big pharma prepared him for the challenge of a new startup.

Today’s model requires a fourth partner-the systems integrator

Mastering digital business strategies and tactics will enable life sciences companies to supercharge innovation and speed therapy discovery, patient centric-practices and improved health outcomes, writes Bhaskar Sambasivan.

Pharma companies today must increasingly provide evidence on real-world outcomes to differentiate and justify their products. But what is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?

In the second of three blogs on how digital strategy and a “data culture” can help define and deliver value, David Ormesher focuses on Value Extraction.

Can the pharma industry truly achieve a patient-centric supply chain? How some clinical trial logistics companies are racing ahead in making the patient a key link in the chain.

Despite delay in enforcement of Drug Supply Chain Security Act's new serialization requirement, getting compliant now is key.

In the second of three blogs on how digital strategy and a “data culture” can help define and deliver value, David Ormesher focuses on Value Creation.

Pharma companies still keep thousands of manufacturing procedures as text documents, an inefficient method can lead to defective batches, recalls and warning letters. Why not use video for training where applicable, asks Boaz Sigelman.

The time is now for pharma to take next steps in tech adoption.

Lisa Kerber outlines how the pharma industry can take advantage of combining new clinical data sources such as diagnostics, or lab data, with AI to deliver on the promise of improving outcomes.

In the first of three blogs on how digital strategy and a “data culture” can help define and deliver value, David Ormesher focuses on Value Creation.

For the life sciences industry in 2017, engaging across social media means less talking-and more listening.

Outlining the new communication priorities necessary to excel in the emerging outcomes-based healthcare landscape.

How artificial intelligence can help pharma filter out the online noise when monitoring for safety signals on the web.

Cherry Cabading and Mona Rakibe outline how the use of modern data management techniques can help companies see improvements in sales effectiveness, data steward productivity and overall data quality.

A recent IT leadership survey found that many more pharma companies are reporting their digital strategies are ineffective compared to other industries. Heath Jackson looks at why this is – and what they need to do about it.

Pieter De Richter explores how the molecular diagnostics landscape-and the very way we think about fighting cancer-is set to change dramatically in the coming decades.

The health promises of big data will not be met unless the right technology is put in place to ensure that data can flow freely and fast across a WAN, writes David Trossell.